News

A patent foramen ovale (PFO) is a common heart defect that may be a potential risk factor for migraine headaches in some patients. The PFO allows venous blood,

In accordance with the terms of the transaction, MGI Pharma has made payments of $45 million, in the aggregate, to AkaRx and its shareholders to acquire certain license

The diagnostic tests rely on circulating tumor cells in patients’ blood. Innogenetics entered into the agreement following the successful conclusion of a feasibility study to convert the current

The marketing authorization application seeks approval for oral alitretinoin for the treatment of severe refractory chronic hand eczema (CHE) and is based on a clinical program comprising almost

Through the collaboration, Campbell University’s experts in pharmaceutical product development will initiate a program to develop a novel formulation for ear infections in children. Jarrett Disbrow, president and

Based on these results, Curagen is discontinuing the development of velafermin, and will continue to focus its resources on belinostat, a Phase II histone deacetylase inhibitor for the

The Phase II study is designed to treat patients with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). The company has also announced top-line results from

Viread has already been approved in the US and EU for the treatment of HIV as part of combination antiretroviral therapy. The submissions contain data from two Phase

Results from this international, multi-center, randomized, double-blind, placebo-controlled study have demonstrated that Lamictal XR reduced partial seizures by 46% over the entire 19-week treatment period, compared to 24%